Hep C Virus - Hepatitis C: serum viral levels recur rapidly after liver transplant

Hepatitis C: serum viral levels recur rapidly after liver transplant
Xagena Medical News - When a diseased liver is removed from a patient with Hepatitis C (HCV), serum viral levels plummet. However, after receiving a healthy liver transplant, virus levels rebound and can surpass pre-transplant levels within a few days. Hepatitis C is the

VGX Pharmaceuticals and DowpharmaSM Sign Research and Development
WebWire - Blue Bell, PA - February 28, 2006, VGX Pharmaceuticals and DowpharmaSM contract manufacturing services, a business unit of The Dow Chemical Company (NYSE: DOW), today announced they have signed a Research and Development Agreement to advance the

Transient Elastography Detects Cirrhosis in Chronic Liver Disease
Medscape News - NEW YORK (Reuters Health) Mar 09 - FibroScan, a noninvasive elastography technique that measures liver stiffness, accurately detects cirrhosis in patients with chronic liver disease, according to a report in the March issue of Gut. "This paper should

Vertex Pharmaceuticals
Forbes - Deutsche Bank Securities initiated coverage of Vertex Pharmaceuticals with a "buy' rating and said the development-stage drug company's promising experimental drug candidate VX-950 has "gold standard" potential as a hepatitis C treatment. "Despite a

Clinical Trial Results Show That Peregrine's First-In-Class Anti-Viral
Medical News Today - Peregrine Pharmaceuticals, Inc. (PPHM), a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it will present top line data demonstrating that its first-in